Mark Froimson, Director at Pacira BioSciences, Inc. (PCRX), sold 1,000 shares at $59.37 ($59K) on 2022-05-09, disclosed to the SEC on 2022-05-11.
Open-market sale of $59k PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2021-03-17 | $106K | — | Filing → |
| PCRX | BUY | 2017-08-16 | $4K | — | Filing → |